Túlio Pfiffer
- Hepatology top 1%
- Oncology top 10%
- Pathology and Forensic Medicine top 5%
- Epidemiology top 10%
- Cancer Research top 10%
- Co-authors
- Davide PastorelliBaek‐Yeol RyooTakuji OkusakaAndrew X. ZhuHyun Cheol ChungPaolo AbadaMasatoshi KudoJoon Oh Park
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Cancer, Lipids, and Metabolism (5 papers)Neuroendocrine Tumor Research Advances (4 papers)
- Partner nations
- BrazilUnited StatesFrance
In The Last Decade
Túlio Pfiffer
19 papers receiving 868 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Hepatology 659
- Oncology 279
- Pathology and Forensic Medicine 263
- Epidemiology 261
- Cancer Research 195
Countries citing papers authored by Túlio Pfiffer
This map shows the geographic impact of Túlio Pfiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Túlio Pfiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Túlio Pfiffer more than expected).
Fields of papers citing papers by Túlio Pfiffer
This network shows the impact of papers produced by Túlio Pfiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Túlio Pfiffer. The network helps show where Túlio Pfiffer may publish in the future.
Co-authorship network of co-authors of Túlio Pfiffer
This figure shows the co-authorship network connecting the top 25 collaborators of Túlio Pfiffer. A scholar is included among the top collaborators of Túlio Pfiffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Túlio Pfiffer. Túlio Pfiffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 27 | |
| 3 | 11 | |
| 4 | 29 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 26 | |
| 8 | Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialbreakdown → | 634 |
| 9 | 25 | |
| 10 | 1 | |
| 11 | 26 | |
| 12 | 1 | |
| 13 | 40 | |
| 14 | 18 | |
| 15 | Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm. A new view on so-called "hepatoid adenocarcinoma of the gallbladder". | 3 |
| 16 | 10 | |
| 17 | 16 | |
| 18 | 1 | |
| 19 | 2 |
About Túlio Pfiffer
Túlio Pfiffer is a scholar working on Hepatology, Cancer Research and Oncology, having authored 19 papers that have together received 882 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer, Lipids, and Metabolism (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Hepatology (659 citations), Pathology and Forensic Medicine (263 citations) and Cancer Research (195 citations). Túlio Pfiffer has collaborated with scholars based in Brazil, United States and France. Frequent co-authors include Davide Pastorelli, Baek‐Yeol Ryoo, Takuji Okusaka, Andrew X. Zhu, Hyun Cheol Chung, Paolo Abada, Masatoshi Kudo, Joon Oh Park, Ian Chau and Jörg Trojan. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.